Current Report · Items 5.07 · 8-K
Mesa Laboratories, Inc.
MLABNASDAQEQUITYCurrent
Submission of Matters to a Vote of Security Holders
ITEM 5.07 SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS On September 8, 2026, the Company held its annual meeting of shareholders (the “Annual Meeting”). Holders of 5,595,869 shares of Mesa’s common stock were entitled to vote, of which 4,872,692 shares were represented in person or by proxy at the Annual Meeting.…
Disclosure sections
Item 5.07Item 5.07 - Submission of Matters to Vote
ITEM 5.07
SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS
On September 8, 2026, the Company held its annual meeting of shareholders (the “Annual Meeting”). Holders of 5,595,869 shares of Mesa’s common stock were entitled to vote, of which 4,872,692 shares were represented in person or by proxy at the Annual Meeting.
The certified results of the matters voted upon at the Annual Meeting, which are more fully described in the Company’s proxy statement for the Annual Meeting, are as follows:
Proposal 1 - Election of directors
Each of John Sullivan, Siddhartha Kadia, Shiraz Ladiwala, Jennifer “Jenny” Alltoft, Mark Capone, Shannon Hall, and R. Tony Tripeny was elected to the Board of Directors of Mesa to hold office for a one-year term, until the 2027 annual meeting of shareholders:
For Withheld Broker
Non-Votes
────────────────────────────────────────────────────────────────────────
John Sullivan, Ph. D. 4,388,976 145,521 338,195
Siddhartha Kadia, Ph. D. 4,421,045 113,452 338,195
Shiraz Ladiwala 4,402,912 131,585 338,195
Jenny Alltoft 4,395,928 138,569 338,195
Mark Capone 4,405,110 129,387 338,195
Shannon Hall 4,399,078 135,419 338,195
R. Tony Tripeny 4,352,734 181,763 338,195
Proposal 2 - Ratification of the selection by our Audit Committee of Baker Tilly US, LLP to serve as the Company’s independent registered public accounting firm for the fiscal year ending March 31, 2027
The appointment of Baker Tilly US, LLP as the Company’s independent registered public accounting firm for the fiscal year ending March 31, 2027 was approved:
For Against Abstain Broker
Non-Votes
──────────────────────────────────────────────────────
4,814,383 56,778 1,531 -
Proposal 3 - Approval on a non-binding basis of the compensation of the Company's named executive officers
The compensation of the Company’s named executive officers, as disclosed in the proxy statement, was approved on a non-binding advisory basis:
For Against Abstain Broker
Non-Votes
──────────────────────────────────────────────────────
4,317,389 136,782 80,326 338,195